Renal functional teratogenesis resulting from adriamycin exposure

Area of Science:

• Toxicology
• Developmental Biology
• Nephrology

Background:

• Adriamycin (doxorubicin) is a chemotherapy agent with known teratogenic potential.
• Prenatal exposure to nephrotoxic agents can lead to long-term renal dysfunction.
• Understanding the specific timing and dose-dependent effects of adriamycin on fetal kidney development is crucial.

Purpose of the Study:

• To investigate the impact of adriamycin exposure during specific gestational periods on the renal functional competence of offspring rats.
• To evaluate the dose-response relationship and critical developmental windows for adriamycin-induced nephrotoxicity.
• To assess various parameters of renal function, including clearance, concentration, dilution, and acid excretion.

Main Methods:

• Pregnant Sprague-Dawley rats were administered adriamycin (0, 1.0, or 1.5 mg/kg/day) via intraperitoneal injection on gestational days 7-10 or 10-12.
• Offspring were assessed for growth, viability, and a comprehensive panel of renal function tests.
• Renal function tests included serum concentrations, clearances, urine concentrating/diluting ability, and acid excretion capacity.

Main Results:

• Exposure during gestational days 7-10 resulted in more overt developmental toxicity.
• Exposure during gestational days 10-12, particularly at higher doses, led to more pronounced alterations in offspring renal function.
• Renal function tests confirmed the nature and magnitude of adriamycin's effects on kidney development.

Conclusions:

• The timing of adriamycin exposure during gestation significantly influences the type and severity of toxicity observed in offspring.
• Gestational days 10-12 represent a more sensitive period for adriamycin-induced renal functional impairment.
• A combination of basal clearance and renal concentrating tests is recommended for detecting prenatal kidney alterations.